SEBI has imposed a penalty totalling Rs60 lakh on Ranbaxy Laboratories’ former independent director VK Kaul and his wife for insider trading in the purchase and sale of scrips of Orchid Chemicals & Pharmaceuticals
Mumbai: Market regulator Securities and Exchange Board of India (SEBI) has imposed a penalty totalling Rs60 lakh on Ranbaxy Laboratories’ former independent director VK Kaul and his wife for insider trading in the purchase and sale of scrips of Orchid Chemicals & Pharmaceuticals, reports PTI.
While Mr Kaul has been fined Rs50 lakh, his wife Ms Bala Kaul has been handed a fine of Rs10 lakh, SEBI said in two separate orders.
The case relates to the sale of 6.5 lakh shares in Orchid Chemicals & Pharmaceuticals (OPCL) by Bear Sterns in March 2008.
The scrip saw a huge fall in the last half of March 2008 but then recovered significantly. Several alerts were generated at the NSE and BSE and the scrip was taken up for joint investigation by the exchanges on the basis of which a report was submitted by them in April that year.
Ms Bala Kaul had bought shares of OCPL from stockbroker Religare Securities on 27-28 March 2008, just prior to the start of share buying by Solrex, a Ranbaxy holding company, on 31 March 2008.
She bought a total of 35,000 shares at an average price of Rs131.71 and sold them on 10 April 2008, at an average price of Rs219.94, the SEBI said in its order.
VK Kaul was at that time serving as an independent director in Ranbaxy Laboratories.
“... It was alleged that noticee (VK Kaul), being a connected person of Ranbaxy Laboratories as per Regulation 2 (c) (i) of SEBI (Prohibition of Insider Trading) Regulations, 1992, had traded on behalf of his wife in the scrip of OCPL based on unpublished price sensitive information...” SEBI said, adding that it led to a violation of its regulations.
SEBI’s Integrated Surveillance Department had also asked the NSE to examine the trading activity in the scrip.
The findings pointed toward insider trading by Ms Bala Kaul and it was observed that her husband had provided her with funds to trade in the scrip of OCPL.
SEBI had in April 2008, sent a show-cause notice to the Kauls to which the noticees gave their replies.
Refuting the noticees contentions, the regulator said that based on circumstantial evidence, “It can be reasonably concluded that the noticee had received/access to Unpublished Price Sensitive Information (UPSI).”
As VK Kaul was at that time an independent director of Ranbaxy Laboratories, the holding company of Solrex, he becomes eligible to be held in violation of insider trading, it said.
As per the latest quarterly data released by AMFI, the cumulative average Assets Under Management of all fund houses stood at about Rs6,87,640 crore in the last quarter of 2011, a decline of Rs16,040 crore from a total of Rs7,03,680 crore in the first quarter of 2011
New Delhi: The mutual fund industry took a hit of more than Rs16,000 crore on its asset size during 2011, even as the newly-crowned market leader HDFC MF grew in size and consolidated its top position, reports PTI.
As per the latest quarterly data released by Association of Mutual Funds in India (AMFI), the cumulative average Assets Under Management (AUM) of all fund houses stood at about Rs6,87,640 crore in the last quarter of 2011.
This marked a decline of Rs16,040 crore from a total of Rs7,03,680 crore in the first quarter or January-March period of 2011.
Experts attributed the fall to the sharp losses in the stock markets, as also to the withdrawals by investors. The funds typically collect money from investors to invest in various asset classes including stocks and debt securities.
The loss was even larger for the cumulative asset base of the top five fund houses (HDFC, Reliance, ICICI Pru, Birla Sunlife and UTI Mutual Funds), as their total average AUM declined by Rs31,741 crore in the same period to end the year at Rs3,60,733.14 crore.
At the end of 2011, HDFC Mutual Fund retained its leadership position with total average AUM of Rs88,737.07 crore. It marked an increase of Rs2,455 crore from the levels in the first quarter of 2011.
HDFC MF was the only one among top five fund houses to register an increase in this period, as the remaining four saw their AUMs decline.
Reliance MF's average AUM dipped by Rs17,417 crore to Rs84,300.35 crore, while that of ICICI Prudential MF dipped by Rs4,080 crore to Rs 69,472.08 crore.
Birla Sunlife MF’s average AUM dipped by Rs3,327 crore to Rs 60,406.30 crore, while the decline was larger at Rs9,371 core for UTI MF, whose average AUM stood at Rs57,817.34 crore in the October-December quarter of 2011.
At the end of 2011, there were a total of 44 fund houses in the country, as against 42 in the first quarter.
A total of eight new stocks have been included in BSE Mid-cap index, while 20 existing ones would move out. In the BSE Small-cap index, the exchange would include 42 new scrips and exclude 40 existing ones. The changes will come into effect from 9th January
Mumbai: The Bombay Stock Exchange (BSE) on Wednesday announced changes in its indices for the mid-cap and small-cap segments, which will come into effect from 9th January, reports PTI.
A total of eight new stocks have been included in BSE Mid-cap index, while 20 existing ones would move out. In the BSE Small-cap index, the exchange would include 42 new scrips and exclude 40 existing ones, according to a BSE statement.
Those joining the mid-cap index include Suzlon Energy, Unitech, Jindal Saw, Tata Coffee, Indiabulls Real Estate, Areva T&D India and Bombay Dyeing & Mfg Co.
On the other hand, companies like GlaxoSmithKline Consumer Healthcare, Gujarat NRE Coke, HCL Infosystems, Orchid Chemicals & Pharmaceuticals, SKS Microfinance and Network 18 Media & Investments have been excluded from the Mid-cap index.
Suven Life Sciences, Zenith Infotech, Hindustan Motors are among those being excluded from the BSE Small-cap index.
Those being included in the Small-cap index include Essar Shipping, Balrampur Chini Mills, S Kumars Nationwide, Sujana Towers and Jyothy Laboratories.
In addition, the BSE has included Emami and Gujarat State Fertilizers & Chemicals Ltd in the BSE TASIS Shariah 50, as part of its periodic review.